Vantage Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3M | Sell |
454,124
-5,563
| -1% | -$384K | 2.28% | 19 |
|
|
2025
Q1 | $31.9M | Sell |
459,687
-120,730
| -21% | -$8.38M | 2.68% | 17 |
|
|
2024
Q4 | $49.9M | Buy |
580,417
+151,620
| +35% | +$13M | 4.35% | 4 |
|
|
2024
Q3 | $51.1M | Sell |
428,797
-105,974
| -20% | -$12.6M | 4.29% | 5 |
|
|
2024
Q2 | $76.3M | Sell |
534,771
-65,020
| -11% | -$9.28M | 6.92% | 2 |
|
|
2024
Q1 | $77M | Buy |
599,791
+116,681
| +24% | +$15M | 6.88% | 1 |
|
|
2023
Q4 | $50M | Buy |
483,110
+175,378
| +57% | +$18.1M | 4.98% | 2 |
|
|
2023
Q3 | $28M | Sell |
307,732
-14,890
| -5% | -$1.35M | 3.67% | 6 |
|
|
2023
Q2 | $26.1M | Buy |
322,622
+13,728
| +4% | +$1.11M | 3.38% | 9 |
|
|
2023
Q1 | $24.4M | Sell |
308,894
-58,500
| -16% | -$4.63M | 3.34% | 10 |
|
|
2022
Q4 | $24.9M | Sell |
367,394
-32,454
| -8% | -$2.2M | 3.86% | 6 |
|
|
2022
Q3 | $19.9M | Sell |
399,848
-578,374
| -59% | -$28.8M | 3.12% | 10 |
|
|
2022
Q2 | $54.5M | Hold |
978,222
| – | – | 4.35% | 7 |
|
|
2022
Q1 | $54.3M | Buy |
+978,222
| New | +$54.3M | 2.71% | 13 |
|